ABSTRACT
Since the release of sildenafil (Viagra, Pfizer) for the treatment of male erectile dysfunction or ED, in 1998, there has been a significant increase in the amount of public and media attention focused on the topic of ‘female sexual dysfunction’ or FSD. In fact, more and more, the medical community and women in general are beginning to understand that FSD may, in part, be due to ‘physical’ or organic issues, and not purely psychologic or psychosexual in nature, as many previously believed. This new understanding has also led to the development of various effective treatment options, which are now available to help women and couples improve their sexual health.
